The FDA has selected Dexcom to participate in its TEMPO pilot program, designed to expedite the introduction of digital health technologies for chronic disease management. This initiative will evaluate the Dexcom Glucose Health Program, which utilizes AI to integrate glucose monitoring with lifestyle data for individuals with type 2 diabetes and prediabetes. The pilot operates under Medicare’s new ACCESS model, emphasizing payment for health outcomes rather than individual services. Dexcom’s involvement signifies a step toward enhancing access to innovative health solutions, aiming to foster proactive healthcare and generate vital real-world evidence for these technologies.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://pharmaphorum.com/news/dexcom-first-join-fdacms-health-tech-pilot
